Company Description
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States.
It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors.
In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals, including pediatric nurse practitioners, echocardiographers, other diagnostic technicians, and exercise physiologists; and specialized cardiac care to the fetus, neonatal and pediatric patients.
Further, the company provides other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians, pediatric gastroenterologists; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments.
The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022.
Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
| Country | United States |
| Founded | 1979 |
| IPO Date | Sep 19, 1995 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 5,450 |
| CEO | Dr. James D. Swift M.D. |
Contact Details
Address: 1301 Concord Terrace Sunrise, Florida 33323 United States | |
| Phone | (954) 384-0175 |
| Website | mednax.com |
Stock Details
| Ticker Symbol | MD |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000893949 |
| CUSIP Number | 58502B106 |
| ISIN Number | US58502B1061 |
| Employer ID | 26-3667538 |
| SIC Code | 8060 |
Key Executives
| Name | Position |
|---|---|
| Dr. James D. Swift M.D. | Chief Executive Officer and Director |
| C. Marc Richards | Executive Vice President and Chief Financial Officer |
| Dr. Curtis B. Pickert M.D. | Executive Vice President and Chief Operating Officer |
| Mary Ann E. Moore | Executive Vice President, General Counsel and Secretary |
| Lee A. Wood | Executive Vice President of National and Market Operations |
| John C. Pepia | Senior Vice President and Chief Accounting Officer |
| Cheryl M. VanPatten | Senior Vice President and Chief Information Officer |
| Daniel Patrick Corcoran | Senior Vice President of Administration and Managed Care |
| Charles W. Lynch C.F.A. | Senior Vice President of Finance, Strategy and Investor Relations |
| Meghan K. Lublin | Senior Vice President, Chief Brand and Communications Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2024 | 8-K | Current Report |
| Mar 28, 2024 | ARS | Filing |
| Mar 28, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Mar 28, 2024 | DEF 14A | Other definitive proxy statements |
| Feb 20, 2024 | 10-K | Annual Report |
| Feb 20, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 12, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |